Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus cream 1% effects on molecular profile in atopic dermatitis
NCT00117377Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00117377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117377.